MentionFox
Home › Stakes › Palisade Bio, Inc.
5%+ stakes · Schedule 13D and 13G

Palisade Bio, Inc.: 5%+ holders

Who has reported owning 5% or more of Palisade Bio, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more8
Filings24
Latest filing2026-08-14

Palisade Bio, Inc. has 24 Schedule 13D or 13G filings on record since 2025-08-14. 8 holders' latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Janus Henderson Group Plc9.99%14,885,421SCHEDULE 13G, 2025-12-082025-11-28
RA Capital Management, L.P.9.9%17,620,479SCHEDULE 13G/A, 2026-05-152026-03-31
Perceptive Advisors LLC7.9%14,113,863SCHEDULE 13G/A, 2026-05-152026-03-31
Soleus Capital Master Fund, L.P.7.5%13,063,687SCHEDULE 13G/A, 2026-08-132026-06-30
Octagon Capital Advisors LP6.4%9,567,898SCHEDULE 13G, 2026-02-102025-12-31
Franklin Resources, Inc.6%9,163,990SCHEDULE 13G, 2026-01-292025-12-31
BlackRock, Inc.6%10,436,760SCHEDULE 13G, 2026-07-292026-06-30
Ameriprise Financial, Inc.5.3%8,711,385SCHEDULE 13G, 2026-05-152026-03-31
Armistice Capital, LLC4.99%478,945SCHEDULE 13G/A, 2025-08-142025-06-30
Squadron Master Fund LP3%4,500,000SCHEDULE 13G/A, 2026-02-172025-12-31
Point72 Asset Management, L.P.0.2%411,772SCHEDULE 13G/A, 2026-05-152026-03-31
Deep Track Capital, LP0%0SCHEDULE 13G/A, 2026-02-132025-12-31
Commodore Capital LP0%0SCHEDULE 13G/A, 2026-08-142026-06-30

Timeline

FiledHolderPercentFiling
2025-08-14Armistice Capital, LLC4.99%SCHEDULE 13G/A
2025-10-07Point72 Asset Management, L.P.6.2%SCHEDULE 13G
2025-10-08Deep Track Capital, LP9.99%SCHEDULE 13G
2025-10-08Commodore Capital LP9.9%SCHEDULE 13G
2025-10-08Squadron Capital Management LLC8.5%SCHEDULE 13G
2025-10-09Perceptive Advisors LLC9.99%SCHEDULE 13G
2025-10-09RA Capital Management, L.P.9.9%SCHEDULE 13G
2025-12-08Janus Henderson Group Plc9.99%SCHEDULE 13G
2026-01-29Franklin Resources, Inc.6%SCHEDULE 13G
2026-02-10Octagon Capital Advisors LP6.4%SCHEDULE 13G
2026-02-13Deep Track Capital, LP0%SCHEDULE 13G/A
2026-02-17Point72 Asset Management, L.P.7%SCHEDULE 13G/A
2026-02-17Perceptive Advisors LLC9.99%SCHEDULE 13G/A
2026-02-17RA Capital Management, L.P.9.9%SCHEDULE 13G/A
2026-02-17Squadron Master Fund LP3%SCHEDULE 13G/A
2026-05-15Point72 Asset Management, L.P.0.2%SCHEDULE 13G/A
2026-05-15Ameriprise Financial, Inc.5.3%SCHEDULE 13G
2026-05-15Perceptive Advisors LLC7.9%SCHEDULE 13G/A
2026-05-15RA Capital Management, L.P.9.9%SCHEDULE 13G/A
2026-05-15Commodore Capital LP7.2%SCHEDULE 13G/A
2026-05-27Soleus Capital Master Fund, L.P.5.4%SCHEDULE 13G
2026-07-29BlackRock, Inc.6%SCHEDULE 13G
2026-08-13Soleus Capital Master Fund, L.P.7.5%SCHEDULE 13G/A
2026-08-14Commodore Capital LP0%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Palisade Bio, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/palisade-bio
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Palisade Bio, Inc. 5%+ holders: 8 at 5% or more, largest Janus Henderson Group Plc 9.99%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/palisade-bio